Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
518.5 USD | -0.27% | +0.75% | +9.96% |
Mar. 20 | Biggest cyberattacks in US healthcare sector | RE |
Mar. 19 | Global markets live: Nvidia, Cisco, BAE Systems, Diageo, Boeing... |
Financials (USD)
Sales 2024 * | 172B | Sales 2025 * | 182B | Capitalization | 121B |
---|---|---|---|---|---|
Net income 2024 * | 8.22B | Net income 2025 * | 9.09B | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 14.51B | Net Debt 2025 * | 11.06B | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
13.2
x | Employees | 104,900 |
Yield 2024 * |
1.21% | Yield 2025 * |
1.28% | Free-Float | 99.51% |
Latest transcript on Elevance Health, Inc.
1 day | -0.27% | ||
1 week | +0.75% | ||
Current month | +3.45% | ||
1 month | +3.07% | ||
3 months | +10.64% | ||
6 months | +15.93% | ||
Current year | +9.96% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 13-09-30 | |
Director/Board Member | 56 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 18 M€ | +6.77% | - | |
2.36% | 907 M€ | +9.60% | - | |
2.07% | 8 M€ | +6.91% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 518.5 | -0.27% | 875,607 |
24-03-27 | 520 | +0.53% | 685,889 |
24-03-26 | 517.2 | +1.35% | 983,117 |
24-03-25 | 510.4 | -0.68% | 572,163 |
24-03-22 | 513.8 | -0.16% | 608,550 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.96% | 121B | |
+21.29% | 103B | |
-24.27% | 41.8B | |
+5.75% | 41.98B | |
+13.71% | 24.07B | |
+2.61% | 3.68B | |
-42.39% | 937M | |
-16.61% | 393M |